argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
26 mar 2024 - 07:07
Statutory name
argenx SE
Title
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
Date last update: 04 April 2026